Polygiene AB (POLYG) AI Stock Analysis

• Market Cap: €473.02M
• Dividend Yield: 2.16%
• Average Volume (3M): 18.01K
• Price to Earnings (P/E): 28.2
• Beta (1Y): 0.95
• Revenue Growth: 35.99%
• EPS Growth: 95.51%
• Country: SE
• Employees: 37
• Sector: Consumer Defensive
• Sector Strength: 53
• Industry: Chemicals - Specialty
• EPS (TTM): 0.00
• Shares Outstanding: 36,526,990
• 10 Day Avg. Volume: 19,436
• 30 Day Avg. Volume: 18,013
• PEG Ratio: -0.48
• Price to Book (P/B): 0.50
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -5.89
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: €13.52
• Price Target Upside: 4.84% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 64 Neutral
• Price Target: kr13.50 ▲(4.65%Upside)

Polygiene AB's overall score is primarily driven by strong technical analysis and robust financial fundamentals, despite profitability challenges. The technical indicators show a positive trend, with the stock trading above all major moving averages. However, the valuation is negatively impacted by a poor P/E ratio due to net losses. The company's stable balance sheet and strong cash flow management provide a solid foundation, but addressing profitability issues will be crucial for improving its valuation.

Polygiene AB Business Overview & Revenue Model

Company Description

Polygiene AB (POLYG) is a Swedish company specializing in antimicrobial and odor-control solutions. As a leader in the textile and materials technology sector, Polygiene offers innovative treatments that prevent the growth of odor-causing bacteria and fungi. The company's core products and services are designed to enhance the hygiene and durability of textiles, apparel, and other materials, providing added value to manufacturers and consumers alike.

How the Company Makes Money

Polygiene AB generates revenue primarily through the sale of its antimicrobial and odor-control treatments to textile and apparel manufacturers. These treatments are applied during the production process to enhance the longevity and hygiene of fabrics. The company's key revenue streams include licensing its technology to manufacturers, direct sales of treatment solutions, and partnerships with brands seeking to incorporate odor-control features into their products. Strategic collaborations with leading brands and manufacturers in various industries also contribute significantly to its earnings, allowing Polygiene to expand its market reach and influence.

Polygiene AB Financial Statement Overview

Summary

Polygiene AB exhibits strong revenue growth and operational efficiency, but struggles with profitability as shown by negative net income margins. The balance sheet is stable with low leverage and high equity financing, while cash flow management is solid despite profitability challenges impacting cash flow ratios.

Income Statement

Polygiene AB's income statement shows a mixed performance. The TTM gross profit margin is approximately 54.35%, indicating effective cost management. However, the TTM net profit margin is negative at -5.02%, reflecting recent net losses. Despite this, the company has shown a positive revenue growth trajectory from 2023 to 2024 with a rate of 38.25%. The EBIT and EBITDA margins also indicate operational efficiency, though profitability remains a challenge.

Balance Sheet

The balance sheet of Polygiene AB is relatively robust with a low debt-to-equity ratio of 0.008, suggesting low leverage. The equity ratio of 91.31% indicates strong equity financing, which enhances financial stability. However, a declining total asset base poses a potential risk for future growth. Return on equity is not available due to negative net income in some periods, highlighting profitability challenges.

Cash Flow

Polygiene AB's cash flow statement exhibits strong operational cash flows with an operating cash flow to net income ratio of 2.06 in TTM, indicating good cash generation relative to net income. The free cash flow has increased by 61.14% from 2023 to 2024, showing improved cash management. However, the free cash flow to net income ratio is negative due to net losses, suggesting profitability issues affecting cash flow.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	170.36M	156.95M	113.54M	173.56M	181.61M	83.93M
Gross Profit	104.33M	103.78M	77.16M	114.57M	115.24M	56.53M
EBITDA	22.45M	18.80M	-305.61M	19.10M	43.99M	701.00K
Net Income	-8.51M	16.83M	-321.95M	8.36M	32.83M	-1.74M
Balance Sheet
Total Assets	331.62M	350.84M	313.78M	621.90M	550.69M	57.64M
Cash, Cash Equivalents and Short-Term Investments	61.91M	68.59M	44.15M	48.06M	52.40M	4.33M
Total Debt	2.33M	2.63M	3.89M	1.64M	2.40M	1.66M
Total Liabilities	28.89M	31.23M	22.53M	29.34M	31.54M	30.16M
Stockholders Equity	302.73M	319.61M	291.25M	592.56M	519.15M	27.48M
Cash Flow
Free Cash Flow	16.39M	22.75M	-4.27M	-50.64M	34.15M	1.03M
Operating Cash Flow	17.57M	24.34M	3.79M	-1.54M	37.60M	2.92M
Investing Cash Flow	-1.54M	-1.59M	-9.42M	-52.11M	-407.47M	-4.04M
Financing Cash Flow	-1.32M	-1.38M	1.95M	47.50M	416.27M	694.00K

Polygiene AB Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 12.90
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:POLYG, the sentiment is Positive. The current price of 12.9 is above the 20-day moving average (MA) of 12.71, above the 50-day MA of 12.36, and above the 200-day MA of 11.63, indicating a bullish trend. The MACD of 0.19 indicates Negative momentum. The RSI at 53.01 is Neutral, neither overbought nor oversold. The STOCH value of 57.61 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:POLYG.

Polygiene AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
POLYG	64 Neutral	€473.02M	28.16	-4.31%	2.16%	35.99%	95.51%
Sector *	63 Neutral	kr25.33B	13.79	52.46%	6.99%	8.63%	-14.01%
AXIC.A	59 Neutral	kr173.21M	―	-27.73%	―	373.74%	46.13%
NEXAM	57 Neutral	kr329.33M	―	-7.20%	―	-3.42%	-31.37%
SERT	47 Neutral	kr151.57M	―	-15.65%	―	-10.46%	-680.00%
ORGC	46 Neutral	€210.95M	―	-55.62%	―	-11.46%	-14.56%
LCLEAN	39 Underperform	kr40.57M	―		―	9.84%	7.38%